TG THROMBOGENICS
Live / Registered — Cancelled — Section 71 (as of 13 May 2022)
What this means for you
Registered since 01 Nov 2011. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79093385
- Registration number
- 4047607
- Mark type
- Design + words
- Filed
- 30 Nov 2010
- Published for opposition
- 16 Aug 2011
- Registered
- 01 Nov 2011
- Attorney of record
- Thomas J. Mango
Goods and services
- Class 001 — Chemicals: Chemical preparations and substances for use in the manufacture of pharmaceuticals
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of diseases and disorders, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer; veterinary preparations for treatment of diseases and disorders in mammalians, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer; sanitary preparations for medical purposes; dietetic foods adapted for medical use, food for babies; medical plasters; material for stopping teeth, dental wax; disinfectants for medical instruments, for hygienic purposes, and for use in medical surgery procedures; preparations for destroying vermin; fungicides, herbicides; biopharmaceutical preparations, namely, anticoagulants, anti angiogenic drugs, anticancer drugs, cardiovascular drugs, protease enzymes, protease inhibitors, antibodies, plasmins, truncated plasmins, microplasmins, plasminogens, truncated plasminogens, microplasminogens, plasminogen activators, staphylokinases for the treatment diseases and disorders, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer; diagnostic medical reagents, chemicals and biological materials, namely, antigen and diagnostic kits consisting primarily of monoclonal and/or polyclonal antibodies, buffers, and reagents for medical laboratory use in disease testing
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research and design of new products in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention, and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; industrial analysis and product research services in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; pharmaceutical, biopharmaceutical, medical, biomedical, biological, biochemical, toxicological and clinical research and product development of diagnostic tests and kits, biopharmaceutical preparations and drugs, and medicines; biopharmaceutical product evaluation; biological, biochemical, pharmaceutical, medical, toxicological and clinical research, scientific research for medical purposes in the treatment of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer diseases and disorders; development services in the field of new biopharmaceutical drugs, preparations and medicines for ophthalmic, vascular and cancer pathologies
- Class 044 — Medical, beauty and agricultural services: Medical services; veterinary services; medical, veterinary and pharmaceutical advisory and consultancy services; medical services, namely, therapeutic, prognostic and diagnostic testing services
Owner
- Oxurion NV, BE
- ThromboGenics NV, B-3001 Heverlee, BE
- ThromboGenics NV, B-3001 Heverlee, BE
Prosecution history
- 26 Feb 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 Jan 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 11 Apr 2023 — TOTAL INVALIDATION PROCESSED BY THE IB
- 01 Mar 2023 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 01 Mar 2023 — INVALIDATION PROCESSED
- 13 Jan 2023 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 13 May 2022 — CANCELLED SECTION 71
- 17 Dec 2020 — INTERNATIONAL REGISTRATION RENEWED
- 01 Nov 2020 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 13 Jun 2019 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 08 Mar 2019 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 26 Jan 2019 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 26 Jan 2019 — INVALIDATION PROCESSED
- 11 Jan 2019 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 28 Sept 2018 — NEW REPRESENTATIVE AT IB RECEIVED